Join us on 12-15-2022 for a live seminar about RNA SEQ
Thanks for your interest in our recent Science webinar, Discovering Antibodies in Months: New Advances in HT-SPR, Single-Cell BCR-Seq and RNA-Seq. Alloy Head of Global Bioanalytics Dr. Lucy Liu presented on our workflow that improve the speed and quality of the antibody discovery process.
Please fill out your contact information, and we will email you shortly with a link to her presentation.
Our DeepImmune Antibody Discovery service integrates industry-leading in vivo and in vitro wet lab technologies with cutting-edge dry lab in silico techniques to discover and optimize the highest quality human monoclonal and bispecific therapeutics, ready for development.
Explore:
Our research facilities:
Boston, MA
Cambridge, UK
Basel, CH
San Francisco, CA
Athens, GA
© 2023 Alloy Therapeutics, Inc. All Rights Reserved.